Advertisement
Advertisement

SXTP

SXTP logo

60 Degrees Pharmaceuticals, Inc. Common Stock

4.05
USD
Sponsored
+0.20
+5.27%
Feb 06, 15:59 UTC -5
Closed
exchange

After-Market

3.75

-0.30
-7.35%

SXTP Earnings Reports

Positive Surprise Ratio

SXTP beat 2 of 9 last estimates.

22%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q3 25 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

60 Degrees Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On Nov 13, 2025, SXTP reported earnings of -2.64 USD per share (EPS) for Q3 25, beating the estimate of -4.93 USD, resulting in a 46.52% surprise. Revenue reached 528.56 thousand, compared to an expected 408.00 thousand, with a 29.55% difference. The market reacted with a -4.88% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
For Q3 2025, 60 Degrees Pharmaceuticals, Inc. Common Stock reported EPS of -$2.64, beating estimates by 46.52%, and revenue of $528.56K, 29.55% above expectations.
The stock price moved down -4.88%, changed from $1.23 before the earnings release to $1.17 the day after.
The next earning report is scheduled for --.
Based on -- analysts, 60 Degrees Pharmaceuticals, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement